Skip to main content

Avin Yaldo, PhD

Director, Health Economics and Outcomes Research, Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ.
Director, Health Economics and Outcomes Research, Bayer HealthCare Pharmaceuticals Inc, Whippany, NJ.
Authored Items
Budgetary Impact of Adding Riociguat to a US Health Plan for the Treatment of Patients with Pulmonary Arterial Hypertension or Chronic Thromboembolic Pulmonary Hypertension
Atheer A. Kaddis, PharmD, Chakkarin Burudpakdee, PharmD, Anshul Shah, BS Pharm, MS, Vijay N Joish, PhD, Christine H. Divers, PhD, Avin Yaldo, PhD
December 2014 Vol 7, No 9 in Practice Management
Last modified: December 23, 2014